Dual Cardiotoxicity of Capecitabine

Key Points

• Cardiotoxicity manifests as vasospastic angina and QT prolongation in patients receiving capecitabine.
• Key evidence includes symptoms of chest pain and heart rhythm disturbances linked to drug exposure.
• This observational case analysis identifies serious adverse effects associated with capecitabine treatment.
• Highlights the need for careful monitoring of cardiac function in patients undergoing capecitabine therapy.